4. Patrick, G. N., et al., Nature, 402, 615-622 (1999).
5. Nikolic, M., et al., Nature, 395, 194-198 (1998).
6. Sanders, C. L., et al., Science, 283, 2083-2085 (1999).
7. Frost, J. A., et al., J. Biol
of N,N-
bis(trichloroacetyl) and N,N-bis(m-bromobenzoyl)
gramicidin S. Arch. Biochem. Biophys., 395(1),
85-93 (2001).
GCY/RXR 5/03
Sigma brand products are sold through Sigma-Aldrich
15:45-52. 6. Polli N. et al (1984):
Characterization by ultrastructural cytochemistry of normal and leukemic myeloid cells
reacting with monoclonal antibodies. Amer.J.Clin.Path. 82:389-395.
Hopper
, M., et al., J. Neuroscience (2005) 25:352-362.
18. Cheng, L., et al., J. Neuroscience (2005) 25:395-403.
19. Kishi, M., et al., Science (2005) 307:929-932.
20. Lee, S., Molecules and Cells (2005) 20
Catalog No. H8264) supplemented with 2% fetal bovine serum (Catalog No. F2442)
using BFP filter set (ex 395-410/em 430-480), GFP filter set (ex 450–490/em 500–550), RFP filter set (ex 530–560/
em 590–650) and
bp
L. pneumophila mip 168 bp
multiplex
L. pneumophila 5S rDNA 108 bp
S. marcescens aac(6' )-Ib 395 bp
C. albicans SAP6 265 bp
Table 3. PCR conditions for other strains
Organisms PCR* Primer Product
Morphological Transformation, Serum-
Independent Growth, and Inhibition of Apoptosis. J. Virol. 72:388-395.
Maina, F., M. C. Hilton, R. Andres, S. Wyatt, T. Klein, and A. M. Davies.
(1998) Multiple Roles
10 L PE wide-necked bottle
PE bottle
Material: HDPE
Nominal volume: 10 L
Weight: min. 395 g
Height: 293 mm
Width: 179 mm
Length: 274 mm
Mouth: S85
Opening: 72.2 mm
Tightness-proven
the dephosphorylated
substrate at Tyr-Ala bond. Purity: ≥98% by HPLC. Exc. max.: ~328 nm; Em. max.: ~395 nm.
Cat. No. 539740 500 µg
Ref.: Nishikata, M., et al. 1999. Biochem. J. 343, 385.
H
N
CH3
(instrument); approx. 395 x 295 x 106 mm (case) •
approx. 155 x 75 x 35 mm (instrument); approx. 340 x 275 x 83 mm (case) •
IP classification Dust and waterproof acc. to IP 68 • •
Storage capacity approx
394 c Jun N Terminal Kinasec-Jun -Terminal nase J4500 55995599 MAPK8 P NP 002741 1NP_002741.1 y y y
395 JNK, Activated (Diphosphorylated JNK) J4750 5599 MAPK8 M NP_002741.1 y y y
430 MAP Kinase Kinase (MEK
394 c Jun N Terminal Kinasec-Jun -Terminal nase J4500 55995599 MAPK8 P NP 002741 1NP_002741.1 y y y
395 JNK, Activated (Diphosphorylated JNK) J4750 5599 MAPK8 M NP_002741.1 y y y
430 MAP Kinase Kinase (MEK
394 c Jun N Terminal Kinasec-Jun -Terminal nase J4500 55995599 MAPK8 P NP 002741 1NP_002741.1 y y y
395 JNK, Activated (Diphosphorylated JNK) J4750 5599 MAPK8 M NP_002741.1 y y y
430 MAP Kinase Kinase (MEK
Morphological Transformation, Serum-
Independent Growth, and Inhibition of Apoptosis. J. Virol. 72:388-395.
Maina, F., M. C. Hilton, R. Andres, S. Wyatt, T. Klein, and A. M. Davies.
(1998) Multiple Roles
Morphological Transformation, Serum-
Independent Growth, and Inhibition of Apoptosis. J. Virol. 72:388-395.
Maina, F., M. C. Hilton, R. Andres, S. Wyatt, T. Klein, and A. M. Davies.
(1998) Multiple Roles
Anti-Cyclin E (Ab-2) Rabbit pAb ELISA, IB human, mouse, rat PC135 100 µl €307
Anti-Cyclin E (Ab-3) (381-395) Rabbit pAb IB, IP human PC�38 500 µg €338
Anti-Cyclin L Rabbit pAb IB, IP human PC705 50 µl €378
desorption process in MALDI. Chem. Rev., 103,
395-425 (2003).
5. Karas, M., and Krüger, R., Ion formation in MALDI. Chem. Rev., 103,
427-439 (2003).
6. Knochenmuss, R., and Zenobi, R., MALDI ionization
y y
392 JAB 1 J3020 P y y y
393 JAK 1 J3774 M y n/d n/d
394 c-Jun N-Terminal Kinase J4500 P y y y
395 JNK, Activated (Diphosphorylated JNK) J4750 M y y y
396 KCNK9 (TASK-3) K0514 M y n/d n/d
397